# Sivelestat Treatment for Postoperative Organ Protection in Type A Aortic Dissection

> **NCT07156656** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 236 (estimated)

## Conditions studied

- Type A Aortic Dissection
- Organ Failure, Multiple

## Interventions

- **PROCEDURE:** Conventional treatment
- **DRUG:** Sivelestat sodium
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07156656
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-01
- **Primary completion:** 2028-09-30
- **Final completion:** 2028-09-30
- **Target enrollment:** 236 (ESTIMATED)
- **Last updated:** 2025-09-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07156656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07156656, "Sivelestat Treatment for Postoperative Organ Protection in Type A Aortic Dissection". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT07156656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*